A simple method to determine phase preference of proteins on live cell membranes
Scientists at National University of Singapore have demonstrated a simple and fast method to determine if a biomolecule partitions into lipid domains on live cell membranes. Their work was published in the Journal of Lipid Research.
Cellular membranes are dynamic assemblies of lipids and proteins with some components organized as domains. Proper cell function requires the partitioning of lipids and proteins into these domains, which are often rich in cholesterol and sphingolipids. However, they are too small (10-200 nm in size) and dynamic (possibly only tens of milliseconds in lifetime) to be observed even with modern super-resolution microscopy techniques.
Traditional methods to determine domain localization involve biochemical assays that require many cells, are prone to artifacts as they are conducted in vitro, and are slow. Although fluorescence-based techniques can probe these domains in live cells, they require specialized instrumentation and are often difficult to interpret.
The research team at NUS developed a simple fluidizer-based method to determine if a molecule prefers to partition into lipid domains on cell membranes.

The team added heptanol to live cells and showed that within 15 minutes it induces clustering of the nanometer-size lipid domains into larger micrometer-size domains that are easily detectable by standard fluorescence microscopes. The method works with both molecules that are genetically labelled with fluorescent proteins and those labelled using extrinsic labels, for example, antibodies.
The work was conducted in the lab of Thorsten Wohland and led by first author Anjali Gupta, who is now a research fellow at Harvard Medical School and Boston Children's Hospital.
Gupta explained the significance of studying phase preference of molecules in membranes.
"Phase preference of molecules in membranes is fundamentally crucial for the essential biological processes originating at membranes, such as T-cell activation, a critical step during an immune response," she said. "Knowledge of the phase preference of molecules will support therapeutic development based on the modulation of lipid domains."
Wohland said: “The phase preference of molecules used to be difficult and time-consuming to establish. This new method, detected by chance, provides results in at most 15 minutes on live cells and can essentially be seen by eye in a simple microscope.”
The team hopes that this technique will enable a quick and facile identification of domain localization and will aid the wider research community.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

RA patient blood reveals joint innerworkings
Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

Defeating deletions and duplications
Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader–Willi syndrome.

Using 'nature’s mistakes' as a window into Lafora disease
After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer’s code through functional connections
A machine learning–derived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.